This technology is a transgenic mouse line with Vps26a heterozygous knockout that can be used to study the role of the retromer core in Alzheimer’s disease.
Pathogenic disruptions in retromer-mediated endosomal trafficking are observed in Alzheimer’s disease (AD). Disruption in the retromer pathway impacts different brain regions with various severity, and the underlying mechanisms of the disease remain unknown. Although a target for studying AD pathology, there are currently no dedicated mouse models to selectively disrupt this pathway.
This technology describes a transgenic mouse line with heterozygous knockout of Vps26a. Western blot analysis confirmed a reduction in Vps26 protein level, but the mice survive into adulthood with no developmental abnormalities. Hippocampal-dependent memory function deficits have been observed in this mouse line with memory-related behavior tasks. This mouse line can also be used to compare with the knockout of other retromer-related genes.
IR CU25396
Licensing Contact: Jerry Kokoshka